Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
15.05
-0.42 (-2.71%)
At close: Sep 12, 2025, 4:00 PM EDT
15.06
+0.01 (0.07%)
After-hours: Sep 12, 2025, 4:57 PM EDT
IART Revenue
Integra LifeSciences Holdings had revenue of $415.61M in the quarter ending June 30, 2025, a decrease of -0.61%. This brings the company's revenue in the last twelve months to $1.62B, up 3.53% year-over-year. In the year 2024, Integra LifeSciences Holdings had annual revenue of $1.61B with 4.47% growth.
Revenue (ttm)
$1.62B
Revenue Growth
+3.53%
P/S Ratio
0.71
Revenue / Employee
$368,912
Employees
4,396
Market Cap
1.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.61B | 68.95M | 4.47% |
| Dec 31, 2023 | 1.54B | -16.09M | -1.03% |
| Dec 31, 2022 | 1.56B | 15.22M | 0.99% |
| Dec 31, 2021 | 1.54B | 170.58M | 12.43% |
| Dec 31, 2020 | 1.37B | -145.69M | -9.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
IART News
- 4 days ago - Integra LifeSciences Still Recovering From Self-Inflicted Wounds - Seeking Alpha
- 4 days ago - Integra LifeSciences Holdings Corporation (IART) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 16 days ago - Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences - GlobeNewsWire
- 6 weeks ago - Integra LifeSciences Holdings Corporation (IART) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Integra LifeSciences Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025 - GlobeNewsWire
- 2 months ago - Integra LifeSciences Announces First Patient Enrolled in Acclarent AERA® Pediatric Registry - GlobeNewsWire
- 3 months ago - INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Integra LifeSciences Holdings Corp. and Encourages Long-Term Investors to Contact the Firm – IART - Accesswire